Repros Therapeutics Inc (RPRX)

[io_io]

<If we want to claim that somehow RPRX management is different then they need to explain WHY they are smarter.>

Why ? Every Biotech management is independent of the next. Its an independent variable. To echo DewD's program bias BS is just plain RHETORIC.

There is absolutely no need to explain why they are smarter, if they are smart enough to get where they are, with a candidate (which Proellex undoubtedly is, a viable candidate) to change medical history. From my desk, that looks smart - what desk do you sit at ?



<The point, very simply, is that biotech have an OVERWHELMING history of making poor decisions about trial design......Why they are different.......Or prove that they have designed this trial correctly.>

When are you going to take notice that in this case, the Phase IIs had placebo controls and active controls, and also that they are of COMPARABLE SIZE to the Phase IIIs ?

So that, almost uniquely with Proellex relative to those other failed drugs you walk about, there is no need for extrapolation of effect from smaller trials (especially O.L. trials) to larger trials.